Elevated tumor markers in a benign lung disease
Authors:
Open Access
- 18 October 2021
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-7
Abstract
Background: This study aimed to determine the underlying pathophysiologic mechanism of elevated carbohydrate antigen 19-9 (CA19-9) in pulmonary sequestration (PS) patients. Materials and methods: Four pulmonary sequestration patients, 12 pneumonia patients and 12 healthy adult volunteers were prospectively studied. Specimens from another 34 pulmonary sequestration patients were retrospectively analyzed. Serum CA19-9 levels of 4 patients were tested before and 1 week, 1 month and 3 months after surgery. The CA19-9 levels of 12 pneumonia patients and 12 healthy adult volunteers were tested as controls. The expression and localization of CA19-9 in diseased lesions and corresponding normal lung tissues were analyzed by Immunohistochemical (IHC). Hematoxylin–eosin (HE) staining was performed to observe the pathological changes in pulmonary sequestration tissues. Results: Serum CA19-9 levels were significantly higher in the 4 patients (797.3 ± 316 IU/ml) than in the pneumonia patients (10.07 ± 5.01 IU/ml) and healthy volunteers (9.85 ± 4.12 IU/ml). In addition, serum CA19-9 levels decreased dramatically after the focus was removed. Positive staining of CA19-9 was found in 70% (24/34) of pulmonary sequestration tissues, and CA19-9 was mainly expressed in the bronchial mucus. In the 4 diseased lesions, deformed alveolar structure and inflammatory cell infiltration were observed, and the degree of damage was positively correlated with serum CA19-9 levels. Conclusions: CA19-9 could be generated by abnormal columnar epithelia in pulmonary sequestration tissues and was transported into circulation after alveoli damage. CA19-9 could serve as an adjuvant diagnostic marker in pulmonary sequestration.Keywords
This publication has 14 references indexed in Scilit:
- Congenital lung malformations: Informing best practiceSeminars in Pediatric Surgery, 2014
- Pulmonary Sequestration Presenting Elevated CA19-9 and CA125 with Ovarian CystsAnnals of Thoracic and Cardiovascular Surgery, 2014
- Embolization versus surgical resection of pulmonary sequestration: Clinical experiences with a thoracoscopic approachJournal of Pediatric Surgery, 2012
- Intralobar Pulmonary Sequestration Associated With Marked Elevation of Serum Carbohydrate Antigen 19-9The Annals of Thoracic Surgery, 2009
- Imaging in bronchopulmonary sequestrationJournal of Medical Imaging and Radiation Oncology, 2009
- Congenital lung malformations?antenatal and postnatal evaluation and managementEuropean Journal of Cardio-Thoracic Surgery, 2005
- Pulmonary sequestrationPaediatric Respiratory Reviews, 2004
- Lessons to be learned: a case study approach Carcinoid tumourlets associated with diffuse bronchiectasis and intralobar sequestrationPerspectives in Public Health, 2000
- Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigenCancer, 1990
- Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinomaJournal of Clinical Immunology, 1982